國立高雄大學圖資館 |

Language: English

Back

Alzheimer's disease II

SpringerLink (Online service)

Alzheimer's disease II

Record Type:	Electronic resources : Monograph/item
Title/Author:	Alzheimer's disease IIedited by Michael S. Wolfe.
other author:	Wolfe, Michael S.
Published:	Cham :Springer International Publishing :2017.
Description:	vii, 202 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Alzheimer's disease.
Online resource:	http://dx.doi.org/10.1007/978-3-319-59460-6
ISBN:	9783319594606$q(electronic bk.)

Alzheimer's disease II
Alzheimer's disease II[electronic resource] /edited by Michael S. Wolfe. - Cham :Springer International Publishing :2017. - vii, 202 p. :ill. (some col.), digital ;24 cm. - Topics in medicinal chemistry,241862-2461 ;. - Topics in medicinal chemistry ;8..

Targets and Strategies Toward the Development of Alzheimer Therapeutics -- The Design, Development, and Evaluation of BACE1 Inhibitors for the Treatment of Alzheimer's Disease -- γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer's Disease -- Inhibitors of Tau-Phosphorylating Kinases -- Microtubule-Stabilizing Agents for Alzheimer's and Other Tauopathies -- PET Imaging Agents for Alzheimer's Disease.

Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine. Therefore, the topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drugability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known guest editors.

ISBN: 9783319594606$q(electronic bk.)

Standard No.: 10.1007/978-3-319-59460-6doiSubjects--Topical Terms:

229397
Alzheimer's disease.

LC Class. No.: RC523

Dewey Class. No.: 616.8311

Alzheimer's disease II
LDR:02641nmm a2200325 a 4500 001 514947
003 DE-He213
005 20170515143859.0
006 m d
007 cr nn 008maaau
008 180126s2017 gw s 0 eng d
020 $a 9783319594606$q(electronic bk.)
020 $a 9783319594590$q(paper)
024 7 $a 10.1007/978-3-319-59460-6 $2 doi
035 $a 978-3-319-59460-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC523
072 7 $a PSB $2 bicssc
072 7 $a SCI013020 $2 bisacsh
082 0 4 $a 616.8311 $2 23
090 $a RC523 $b .A478 2017
245 0 0 $a Alzheimer's disease II $h [electronic resource] / $c edited by Michael S. Wolfe.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a vii, 202 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Topics in medicinal chemistry, $x 1862-2461 ; $v 24
505 0 $a Targets and Strategies Toward the Development of Alzheimer Therapeutics -- The Design, Development, and Evaluation of BACE1 Inhibitors for the Treatment of Alzheimer's Disease -- γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer's Disease -- Inhibitors of Tau-Phosphorylating Kinases -- Microtubule-Stabilizing Agents for Alzheimer's and Other Tauopathies -- PET Imaging Agents for Alzheimer's Disease.
520 $a Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine. Therefore, the topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drugability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known guest editors.
650 0 $a Alzheimer's disease. $3 229397
650 0 $a Alzheimer's disease $x Chemotherapy. $3 188753
650 1 4 $a Chemistry. $3 188628
650 2 4 $a Medicinal Chemistry. $3 275183
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Receptors. $3 337756
650 2 4 $a Neurosciences. $3 211508
700 1 $a Wolfe, Michael S. $3 785185
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Topics in medicinal chemistry ; $v 8. $3 567153
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-59460-6
950 $a Chemistry and Materials Science (Springer-11644)